Studies of human gene mutations provide insights into the complex processes of cardiac remodeling and heart failure, showing promise for defining novel therapeutic targets.
Factors that render patients with cardiovascular disease at high risk for heart failure remain incompletely defined. Recent insights into molecular genetic causes of myocardial diseases have highlighted the importance of single-gene defects in the pathogenesis of heart failure. Through analyses of the mechanisms by which a mutation selectively perturbs one component of cardiac physiology and triggers cell and molecular responses, studies of human gene mutations provide a window into the complex processes of cardiac remodeling and heart failure. Knowledge gleaned from these studies shows promise for defining novel therapeutic targets for genetic and acquired causes of heart failure.
Morita et al. (Tue,) conducted a review in Heart failure. Genetic mutations was evaluated. Studies of human gene mutations provide insights into the complex processes of cardiac remodeling and heart failure, showing promise for defining novel therapeutic targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: